Cobram Estate Olives

The Business

Cobram Estate is the dominant olive oil producer in Australia and, since its 2026 acquisition of California Olive Ranch (COR), the largest producer in the United States as well. The model is fully vertically integrated: it grows olives across roughly 10,000 hectares of company-owned groves, presses the oil in its own mills, and bottles it under its own brands rather than selling as a commodity input. Branded product makes up more than 95% of revenue. This is the opposite of a commodity trader passing through Mediterranean import prices; it is closer to a branded food manufacturer that happens to own its own farmland.

Recent Performance

Revenue rose 11.3% in FY26 to $268.9 million, but earnings told a different story: EBITDA (earnings before interest, tax, depreciation and amortisation, a proxy for underlying cash profit) nearly halved from $116.6 million to $61.4 million as an "off-year" harvest coincided with normalising global olive oil prices. The company posted a net loss of $4.2 million. The COR acquisition, meant to diversify earnings, missed its earn-out target and required an inventory writedown, adding to the disappointment.

Outlook

FY27 is set up to look considerably stronger than FY26 on paper, with a full year of COR contribution and a return to the "on-year" side of the harvest cycle both pushing revenue and EBITDA in the same direction. Strip out those two mechanical effects, however, and underlying organic growth runs closer to 4-5% a year, a more useful read of the business's steady-state growth rate. The biennial harvest pattern means margins will keep oscillating from one year to the next, compressing in "off-year" periods before recovering in "on-year" ones, a swing investors should expect to repeat rather than interpret as deterioration.

Key Risks

Leverage concentration is the dominant risk. Debt and lease obligations of roughly $512 million sit against an enterprise value we estimate near $725 million, a capital structure that leaves little room for a disappointing harvest or a slower-than-expected COR integration; in downside scenarios, equity value could be materially impaired. COR's true annualised US revenue is not disclosed in public filings, and the range of plausible estimates is wide enough to leave genuine uncertainty over whether the acquisition was fairly priced. Normalising Mediterranean olive oil supply also threatens 200 to 400 basis points of margin erosion on Cobram's branded premium as global prices retreat from the highs of FY24 and FY25.

What to Watch

The thesis-defining event is the FY27 first-half result, due in February 2027, which will reveal COR's actual US revenue run-rate for the first time. That single disclosure matters more to this stock's investment case than any other data point on the calendar.

• Feb 2027 FY27 H1 results — reveals COR's true revenue scale, the single largest unknown in the valuation.
• Aug 2027 FY27 full-year results — confirms the on-year harvest recovery and early deleveraging progress.
• Nov 2028 CBA facility refinancing — tests whether lenders view the balance sheet as manageable.

Company Description

Cobram Estate Olives grows, processes, bottles and markets olive oil across two continents. The Australian division, built over more than two decades, farms company-owned and leased groves and holds the number one branded supermarket position with around 36% share of the category. The US division was transformed in March 2026 by the acquisition of California Olive Ranch, which made Cobram the largest olive oil producer in the United States, with distribution now reaching roughly 45,000 retail stores. Both divisions run the same integrated model: own the trees, run the mills, bottle the oil, and sell branded product rather than bulk commodity. Branded revenue exceeds 95% of the group total, insulating margins from the volatility that hits pure commodity importers.

Where the Growth Is

The most important driver over the next three to six years is grove maturation, not new plantings or price increases. Roughly 25% of Australian groves and 37% of US groves are still immature, meaning they have not yet reached peak yield per hectare. As these trees age, production per hectare rises without a corresponding increase in fixed costs such as land, irrigation or mill capacity, which mechanically expands margin at the grove level. This growth is structural and largely independent of global olive oil prices, though it will take several more harvest cycles to fully play out.

Competitive Position

The core competitive advantage is time: a newly planted olive grove takes roughly eight years to reach commercial maturity, and Cobram's existing 10,000 hectares represent decades of accumulated investment that no new entrant can replicate on any faster timeline. This barrier has held Australian market share broadly stable near 36% even as private label and imported brands compete on price. The COR acquisition extends the same moat into the US, where Cobram is now the largest producer by volume in a market still growing 4-5% a year on rising per-capita consumption. The advantage is real but not widening: import competition and retailer private label remain live threats, and the moat protects volume and shelf position more than pricing, which is ultimately set by global supply conditions the company does not control.

Management & Capital Discipline

Management, led by co-founders with more than two decades in olive oil, completed the multi-decade Australian grove development program and then used the balance sheet to acquire US production leadership through the COR deal. That acquisition was struck at leverage of roughly 4.8 times two-year rolling earnings, aggressive for a business with an inherently volatile, biennial harvest cycle. Management has been transparent about the resulting problems, disclosing the COR earn-out miss and describing trading conditions candidly. What has not been disclosed is COR's actual annualised revenue, arguably the single most important number for investors assessing whether the acquisition was fairly priced.

Financial Position

The balance sheet is the weak point in an otherwise capable operating business. Net debt plus lease liabilities of roughly $512 million sit against an enterprise value we estimate at $725 million, a ratio that leaves little room for a disappointing harvest or a slower-than-expected COR integration. Net debt against two-year rolling EBITDA sits near 4.8 times, well above what a food manufacturer would typically carry. Roughly $103 million of undrawn facilities provide near-term headroom, but the business cannot comfortably absorb a second consecutive weak result without covenant pressure.